The deal is the latest in a string of overseas acquisitions by the Ahmedabad drugmaker as it looks to diversify and strengthen its specialty plays in regulated markets. The deal is the latest in a string of overseas acquisitions by the Ahmedabad drugmaker as it looks to diversify and strengthen its specialty plays in regulated markets. by Soban News (international And National News)
